North Capital, Inc. Novartis Ag Transaction History
North Capital, Inc.
- $106 Billion
- Q1 2025
A detailed history of North Capital, Inc. transactions in Novartis Ag stock. As of the latest transaction made, North Capital, Inc. holds 1,163 shares of NVS stock, worth $131,942. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,163Holding current value
$131,942% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,502Shares Held
130MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.39 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.25 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$928 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$779 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$633 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $244B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...